Cetera Investment Advisers Guardant Health, Inc. Transaction History

Cetera Investment Advisers

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $156,839 - $212,920	-1,768 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$98.77 - $132.17 $73,583 - $98,466	-745 Reduced 29.65%	1,768 $221,000
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $44,127 - $66,603	402 Added 19.04%	2,513 $312,000
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $433,841 - $611,626	-3,415 Reduced 61.8%	2,111 $322,000
Q4 2020 Feb 17, 2021	BUY	$99.96 - $135.93 $552,378 - $751,149	5,526 New	5,526 $712,000
Q3 2019 Nov 06, 2019	SELL	$62.59 - $110.3 $150,216 - $264,720	-2,400 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$63.94 - $91.11 $153,456 - $218,664	2,400 New	2,400 $206,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.63B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

Stay updated on Cetera Investment Advisers with notifications on news.